Latest News

Tools and Resources Articles

Filter by:
Topic
Clear filter
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Epcoritamab-bysp

May 19, 2023

Shaniya Pleasant, PharmD/MHCI Candidate and Bradley Yelvington, PharmD, BCOP from Vanderbilt University Medical Center write about epcoritamab-bysp

Tools and Resources Late Breaking News

Immune Checkpoint Inhibitors Make Great Strides in Hepatocellular Carcinoma

May 18, 2023

STRIDE presents an alternative first-line choice for patients with unresectable HCC with a manageable side effect profile and a 22% reduction in risk of death over sorafenib

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Retifanlimab-dlwr

March 22, 2023

Bernard Marini, PharmD, BCOP, Clinical Pharmacist Specialist at University of Michigan College of Pharmacy writes about Retifanlimab-dlwr.

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Pirtobrutinib

January 27, 2023

Andy Hawn, 2025 PharmD Candidate and Erin Kelley, PharmD, BCOP at the Masonic Cancer Clinic Infusion Pharmacy write about Pirtobrutinib

Tools and Resources Late Breaking News

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024

January 18, 2023

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Mosunetuzumab

December 22, 2022

Bernard Marini, PharmD, BCOP Clinical Pharmacist Specialist – Hematology/Oncology Clinical Associate Professor University of Michigan College of Pharmacy writes about Mosunetuzumab.

Imaging scan of lung cancer
Tools and Resources Drug Updates

Pharmacist Application to Practice: Adagrasib

December 22, 2022

Sam Palmatier, Pharmacy Intern and Jeff Engle, PharmD, MS, Oncology Pharmacy Manager at Fairview Cancer Clinic – Edina write about

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Olutasidenib

December 01, 2022

Bernard Marini, PharmD, BCOP, Clinical Pharmacist at University of Michigan College of Pharmacy writes about Olutasidenib

Scan of human lungs
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Tremelimumab

November 10, 2022

Tremelimumab (IMJUDO, AztraZeneca Pharmaceuticals) approved November 10, 2022 for metastatic non-small cell lung cancer and approved October 24, 2022 for unresectable hepatocellular carcinoma

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Teclistamab-cqyv

October 25, 2022

Gavyn Walsh, PD3 Oncology Pharmacy Intern and Erin Kelley, PharmD, BCOP at M Health Fairview Masonic Cancer Clinic write about teclistamab-cqyv

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Futibatinib

September 30, 2022

Mei Ka Fong, Pharm.D., BCOP Clinical Pharmacist Coordinator Levine Cancer Institute, Atrium Health writes about Futibatinib

Pharmacist talking to a customer
Tools and Resources

Leading Oncology Healthcare Providers Release Online IV Cancer Treatment Education Sheets

September 03, 2021

The IVE website provides healthcare workers the latest education material for intravenous cancer treatments, communicating vital information to help caregivers and those experiencing cancer.